Effects of rivastigmine treatment on the neuropsychiatric andbehavioral disturbances of nursing home residents with moderate to severeprobable Alzheimer's disease: A 26-week, multicenter, open-label study |
the Rivastigmine Nursing Home Study Team;Cummings, J.L.;Koumaras, B.;Chen, M.;Mirski, D.; |
The American Journal of Geriatric Pharmacotherapy |
2005-09-01 |
查看 |